This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200509-1380OCv1 174/4/386    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simpson, A. Articles by Custovic, A. Search for Related Content PubMed PubMed Citation Articles by Simpson, A. Articles by Custovic, A.

Endotoxin Exposure, CD14, and Allergic Disease

An Interaction between Genes and the Environment

Academic Division of Medicine and Surgery South, North West Lung Centre, Wythenshawe Hospital; and Centre for Integrated Genomic Medical Research, University of Manchester, Manchester, United Kingdom

Correspondence and requests for reprints should be addressed to Adnan Custovic, M.D., Ph.D., North West Lung Centre, Wythenshawe Hospital, Manchester M23 9LT, UK. E-mail: adnan.custovic{at}manchester.ac.uk

Rationale: High endotoxin exposure may reduce the risk of allergic sensitization.

Objective: To determine the relationship between a promoter polymorphism in the CD14 gene (CD14/–159 C to T) and endotoxin exposure in relation to the development of allergic sensitization, eczema, and wheeze within the setting of a birth cohort.

Methods: We genotyped 442 children (CD14/–159 C to T; rs2569190). We assessed children for allergic sensitization (IgE > 0.2 kU/L to at least one of seven allergens), eczema (physical examination), and parentally reported wheeze. Endotoxin was measured in house dust.

Main Results: Genotype frequencies were consistent with other populations (TT, 25%; CT, 47%; CC, 28%). Sensitization (present in 33% of children) was not associated with genotype. For children with TT and CT genotypes, there was no association between endotoxin and sensitization (odds ratio [OR], 0.95; 95% confidence interval [CI], 0.71–1.23; p = 0.7; and OR, 0.90; 95% CI, 0.77–1.04; p = 0.16, respectively) or endotoxin and eczema (OR, 0.99; 95% CI, 0.81–1.20; p = 0.89; and OR, 1.38; 95% CI, 0.83–2.30; p = 0.22, respectively). In children with the genotype CC, increasing endotoxin load was associated with a marked and significant reduction in the risk of sensitization (OR, 0.70; 95% CI, 0.55–0.89; p = 0.004) and eczema (OR, 0.73; 95% CI, 0.56–0.95; p = 0.02). However, we observed an increased risk of nonatopic wheeze with increasing endotoxin exposure in children with the CC genotype (OR, 1.42; 95% CI, 1.01–1.99; p = 0.04) but not other genotypes. No effect was seen for atopic wheeze.

Conclusions: Increasing endotoxin exposure is associated with reduced risk of allergic sensitization and eczema but with increased risk of nonatopic wheeze in children with the CC genotype at –159 of the CD14 gene. The impact of environmental endotoxin may be enhanced in individuals with this genotype.

Key Words: allergy • asthma • genetics

This article has been cited by other articles:

				L. A. M. Smit, D. Heederik, G. Doekes, E. J. M. Krop, G. T. Rijkers, and I. M. Wouters Ex vivo cytokine release reflects sensitivity to occupational endotoxin exposure Eur. Respir. J., October 1, 2009; 34(4): 795 - 802. [Abstract] [Full Text] [PDF]

				J. D Thrasher and S. Crawley The biocontaminants and complexity of damp indoor spaces: more than what meets the eyes Toxicology and Industrial Health, October 1, 2009; 25(9-10): 583 - 615. [Abstract] [PDF]

				D. L. Nicolae and C. Ober (Too) Great Expectations: The Challenges in Replicating Asthma Disease Genes Am. J. Respir. Crit. Care Med., June 15, 2009; 179(12): 1078 - 1079. [Full Text] [PDF]

				L. A. M. Smit, V. Siroux, E. Bouzigon, M.-P. Oryszczyn, M. Lathrop, F. Demenais, F. Kauffmann, and on behalf of the Epidemiological Study on the Gene CD14 and Toll-like Receptor Gene Polymorphisms, Country Living, and Asthma in Adults Am. J. Respir. Crit. Care Med., March 1, 2009; 179(5): 363 - 368. [Abstract] [Full Text] [PDF]

				P. A. Eggleston Complex Interactions of Pollutant and Allergen Exposures and Their Impact on People With Asthma Pediatrics, March 1, 2009; 123(Supplement_3): S160 - S167. [Abstract] [Full Text] [PDF]

				P. Bogaert, K. G. Tournoy, T. Naessens, and J. Grooten Where Asthma and Hypersensitivity Pneumonitis Meet and Differ: Noneosinophilic Severe Asthma Am. J. Pathol., January 1, 2009; 174(1): 3 - 13. [Abstract] [Full Text] [PDF]

				A. Henderson What have we learned from prospective cohort studies of asthma in children? Chronic Respiratory Disease, November 1, 2008; 5(4): 225 - 231. [Abstract] [PDF]

				R. L. Miller and S.-m. Ho Environmental Epigenetics and Asthma: Current Concepts and Call for Studies Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 567 - 573. [Abstract] [Full Text] [PDF]

				S McLeish and S W Turner Gene environment interactions in asthma Arch. Dis. Child., November 1, 2007; 92(11): 1032 - 1035. [Abstract] [Full Text] [PDF]

				E. von Mutius Asthma and Allergies in Rural Areas of Europe Proceedings of the ATS, July 1, 2007; 4(3): 212 - 216. [Abstract] [Full Text] [PDF]

				F. D. Martinez CD14, Endotoxin, and Asthma Risk: Actions and Interactions Proceedings of the ATS, July 1, 2007; 4(3): 221 - 225. [Abstract] [Full Text] [PDF]

				W. C. Moore and S. P. Peters Update in Asthma 2006 Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 649 - 654. [Full Text] [PDF]

				F. D. Martinez Gene-Environment Interactions in Asthma: With Apologies to William of Ockham Proceedings of the ATS, January 1, 2007; 4(1): 26 - 31. [Abstract] [Full Text] [PDF]

				M. Kabesch A Glitch in the Switch?: Of Endotoxin, CD14, and Allergy. Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 365 - 366. [Full Text] [PDF]